Timothy J. Sangiovanni insider trades

Open-market stock purchases and sales by Timothy J. Sangiovanni, SVP, Finance & Corp Controller at Zevra Therapeutics, Inc, from SEC Form 4 filings since Jan 25, 2018.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +193%.

Recent trades

DateStockTradeValue
May 28, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
May 28, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Feb 3, 2026ZVRA Zevra Therapeutics, IncSold$27.5K
Jan 31, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Jan 30, 2026ZVRA Zevra Therapeutics, IncSold$15.4K
Jan 30, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—

Companies traded

  • ZVRA Zevra Therapeutics, Inc: 2 buys, 3 sales, last May 28, 2026
  • KMPH Kempharm, Inc: 7 buys, last Jan 9, 2023

Get free alerts when Timothy J. Sangiovanni files a new trade →